Randomized Trial of Warfarin Nomograms
- Michael J. Kovacs, MD, FRCPC; and
- Philip S. Wells, MD, FRCPC, MSc
- From London Health Sciences Centre, London, Ontario N6A 4G5, Canada, and Ottawa Hospital—Civic Campus; Ottawa, Ontario K1Y 4E9, Canada.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
IN RESPONSE:
We thank all of the correspondents for the interest in our article, which has initiated a strong and emotional debate. Given the …
RSS Feeds









